Your Wellness Goals: Are you aiming for medical weight loss, enhanced energy, or overall immune support
because rigorously controlled human safety data specific to the TB-500 fragment does not exist, its longer-term risk profile, including possible immune reactions, remains unknown Evidence snapshot: Evidence for TB-500 itself is preclinical, drawn mainly from cell-culture and animal studies (a 1999 rat wound-healing study and later rodent cardiac- and tendon-injury models), with a 2026 scoping review describing the musculoskeletal literature on thymosin beta-4 and TB-500 as sparse and largely preclinical
Using regular sterile water (no preservative), shaking instead of swirling, or storing at room temp degrades the peptide fast
Splitting the daily dose into morning and evening injections maintains steadier peptide availability for ongoing tissue support
Davis R, Barolat-Romana G, Engle H